"To demonstrate a reduction on that end-point requires a significant mortality rate in the placebo arm, which is not being seen with the current enrollment"
Spot on; like what I've been banging on about since the start of this year, for the trial to be successful we need the placebo cohort to die.
For all the outraged SHs you got your wish, the placebo cohort lived so now why the sad face? How else did you think we would have achieved the primary endpoint.
"To demonstrate a reduction on that end-point requires a...
-
- There are more pages in this discussion • 421 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |